Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

Cytokine-modified tumour cells have been used in clinical trials for immunotherapy of neuroblastoma, but primary tumour cells from surgical biopsies are difficult to culture. Autologous fibroblasts, however, are straightforward to manipulate in culture and easy to transfect using nonviral or viral v...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, S E, Grosse, S M, Siapati, E K, Kritz, A, Kinnon, C, Thrasher, A J, Hart, S L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360308/
https://www.ncbi.nlm.nih.gov/pubmed/17595664
http://dx.doi.org/10.1038/sj.bjc.6603857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360308/
https://www.ncbi.nlm.nih.gov/pubmed/17595664
http://dx.doi.org/10.1038/sj.bjc.6603857

Ejemplares similares